510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2523-2018Class II

Brivo XR385, model 5215463, Digital Diagnostic Radiographic System

GE Healthcare / initiated 2016-09-16 / Terminated

GE Healthcare, LLC began a recall of Brivo XR385, model 5215463, Digital Diagnostic Radiographic System on . FDA classified it as Class II and gives the reason as "The placing of weight on the VRAD detector, of the Brivo XR385 digital radiographic system, can introduce image artifacts, which can result in patient exam retakes". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2523-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
GE Healthcare
Product
Brivo XR385, model 5215463, Digital Diagnostic Radiographic System
Product code
KPR System, X-Ray, Stationary
Reason for recall
The placing of weight on the VRAD detector, of the Brivo XR385 digital radiographic system, can introduce image artifacts, which can result in patient exam retakes.
FDA root cause
Component change control
Action
An Important Electronic Product Radiation Warning letter was sent to consignees beginning 9/16/2016. The letter identified affected product, described the issue, and stated that GE will correct the devices without charge. Questions can be directed to 1-800-437-1171.
Quantity in commerce
58 (55 US, 3 OUS)
Distribution
AK, AL, AZ, CA, CT, FL, GA, HI, IA, IL, KS, KY, LA, MA, MD, MS, NJ, NM, OR, PA, TN, TX, VA, and Guam, and Canada.
Product codes and lots
Mfg Lot or Serial # / System ID:  000A1E36N037X1 / 319668B385, 000A1E36N037X1 / GON4182034 , 000A1E38N026L1 / 504EJLKV1, 000A1E38N026N2 / 907983BRIVO, 000A1E38N026R1 / 316630BRIVO, 000A1E38N026U2 / 319754B385, 000A1E38N026V1 / 860678BRIVO, 000A1E44N025A1 / 201567RAD1, 000A1E44N025G1 / 409295BRIVOXR, 000A1E44N025K2 / 860658XR385, 000A1E44N025O1 / 214MHXR385, 000A1E44N025V1 / 402384NHIRAD, 000A1E44N025Y1 / 256ODCRAD1, 000A1E44N025Z1 / 760323BRIVO1, 000A1E4BN003V2 / 772335B385, 000A1E4CN012F2 / 270737RAD1, 000A1E4CN012G1 / 804281XR385, 000A1E4CN012O1 / 240707RAD, 000A1E4CN012Q1 / 305MMC385, 000A1E4CN012T1 / 615396DR, 000A1E4CN076H2 / 203422BRIVO, 000A1E4CN076M1 / 856291BRIVO, 000A1E4CN076N1 / 808AAOMBRIVO, 000A1E4CN076R2 / 850325BC385, 000A1E4CN077P1 / 780875RAD, 000A1E4CN077R2 / 905850XR1, 000A1E4CN077V2 / 210INWD385ER, 000A1E52N024C2 / 623561XR385, 000A1E57N059P2 / 240707RAD, 000a1E57N060K2 / 813873BR1, 000A1E57N060L2 / 661KMSXR2, 000A1E57N060T2 / 707464BRIVO, 000A1E57N060W1 / 325655RAD, 000A1E57N060X1 / 973292BRIVO, 000A1E57N060X2 / 815464XR385, 000A1E57N060Y1 / 413447BRIVO, 000A1E5AN058C1 / 813906DR1, 000A1E5AN058D2 / 805898BRIVO1, 000A1E5AN058J1 / 508862BRIVO, 000A1E5AN058J2 / 575627BR385, 000A1E5AN058L1 / 671FHPBRIVO, 000A1E5AN058O2 / 508778XR385, 000A1E5AN058W1 / 541789BRIVO, 000A1E5AN058Y2 / 954PALMSXR, 000A1E5AN058Y2 / AM14GBU59, 000A1E5AN058Z1 / 415526BRIVO, 000A1E5AN059K1 / 306625XR385, 000A1E5AN059M2 / 662647BRIVO, 000A1E5AN059V2 / 575542BR385, 000A1E5AN059Y2 / PROVXR385, 000A1E5CN061G1 / 505609B385, 000A1E5CN061J1 / 863419BRI, 000A1E5CN061L1 / 404616BRIVO, 000A1E5CN061M1 / 615220PBRIVO, 000A1E5CN061V1 / 856355XR385, 000A1E5CN062H1 / 217774SXR, A1E5AN058X1 / 508548XR385, A1E67N001A2 / SLP385.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2523-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2523-2018Class IITerminatedVoluntary: Firm initiated